Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db84f70601728474fe41a4dfec7454ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
2001-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afca73f9862253e5f1c9755ef14b529b |
publicationDate |
2001-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0170742-A1 |
titleOfInvention |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents |
abstract |
A compound of formula (IV) or a pharmaceutically acceptable salt thereof as defined in the specification. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11072610-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013152063-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1972627-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008113558-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9315499-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249158-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013152065-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8513420-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667613-B2 |
priorityDate |
2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |